Table 1 FOXG1 variants in new patients with FOXG1 syndrome
From: FOXG1 syndrome: genotype–phenotype association in 83 patients with FOXG1 variants
Pt. ID | Fam. ID | Age (months) | FOXG1 variant | Coding effect | FOXG1 domain | Segregation | Method | Classification of variant 21 | Known FOXG1 variation | |
---|---|---|---|---|---|---|---|---|---|---|
2 | 2 | 51 | c.214 C > T | p.(Q72*) | Nonsense | N-terminal | De novo | FOXG1 Sanger sequencing | Pathogenic | Novel |
1 | 1 | 40 | c.256delC | p.(Q86Rfs*106) | Frameshift | N-terminal | De novo | FOXG1 Sanger sequencing | Pathogenic | |
5 | 5 | 105 | c.385delG | p.(E129Sfs*63) | Frameshift | N-terminal | De novo | FOXG1 Sanger sequencing | Pathogenic | Novel |
3 | 3 | 33 | c.406 G > T | p.(E136*) | Nonsense | N-terminal | De novo | Exome | Pathogenic | Hgmd: cm152585 |
4 | 4 | 100 | c.460dupG | p.(E154Gfs*301) | Frameshift | N-terminal | De novo | FOXG1 Sanger sequencing | Pathogenic | |
6 | 6 | 39 | c.460delG | p.(E154Rfs*38) | Frameshift | N-terminal | De novo | FOXG1 Sanger sequencing | Pathogenic | Novel |
7 | 7 | 72 | c.460dupG | p.(E154Gfs*301) | Frameshift | N-terminal | N.A. | NGS panel epileptic encephalopathy | Pathogenic | |
8 | 8 | 45 | c.460dupG | p.(E154Gfs*301) | Frameshift | N-terminal | De novo | NGS panel epilepsy | Pathogenic | |
9 | 9 | 61 | c.460dupG | p.(E154Gfs*301) | Frameshift | N-terminal | De novo | NGS panel epilepsy and epileptic encephalopathy | Pathogenic | |
10 | 10 | 23 | c.517 G > T | p.(E173*) | Nonsense | N-terminal | De novo | Trio-exome | Pathogenic | Novel |
11 | 11 | 82 | c.543 G > C | p.(K181N) | Missense | Forkhead cs | PGM | NGS panel epileptic encephalopathy and microcephaly | Pathogenic | Novel |
12 | 11 | 34 | c.543 G > C | p.(K181N) | Missense | Forkhead cs | PGM | FOXG1 Sanger segregation | Pathogenic | Novel |
13 | 13 | 85 | c.545 C > A | p.(P182Q) | Missense | Forkhead cs | De novo | NGS panel epileptic encephalopathy | Pathogenic | Novel |
14 | 14 | 93 | c.553 A > T | p.(S185C) | Missense | Forkhead cs | De novo | NGS panel epileptic encephalopathy | Likely pathogenic | Novel |
15 | 15 | 192 | c.561 C > A | p.(N187K) | Missense | Forkhead cs | De novo | Trio-exome | Pathogenic | Novel |
16 | 16 | 62 | c.561 C > A | p.(N187K) | Missense | Forkhead cs | De novo | Trio-exome | Pathogenic | Novel |
17 | 17 | 20 | c.565 C > T | p.(L189F) | Missense | Forkhead cs | De novo, identical twins | FOXG1 Sanger sequencing | Pathogenic | Novel |
18 | 17 | 33 | c.565 C > T | p.(L189F) | Missense | Forkhead cs | De novo, identical twins | FOXG1 Sanger segregation | Pathogenic | Novel |
19 | 19 | 72 | c.581 T > G | p.(l194S) | Missense | Forkhead cs | De novo | NGS panel epileptic encephalopathy | Likely pathogenic | Novel |
30 | 30 | 47 | c.590 G > T | p.(S197I) | Missense | Forkhead | De novo | Trio-exome | Pathogenic | Novel |
20 | 20 | 25 | c.592_594delCCC | p.(P198del) | In-frame | Forkhead | De novo | FOXG1 Sanger sequencing | Likely pathogenic | Novel |
21 | 21 | 46 | c.609_616del GCTCAACG | p.(L204Hfs*248) | Frameshift | Forkhead | De novo | Trio-exome | Pathogenic | Novel |
22 | 22 | 28 | c.624 C > G | p.(Y208*) | Nonsense | Forkhead | De novo | NGS panel epileptic encephalopathy | Pathogenic | |
23 | 23 | 31 | c.730 C > T | p.(R244C) | Missense | Forkhead | De novo | NGS panel microcephaly | Pathogenic | Reported7 |
24 | 24 | 14 | c.732_741del | p.(H245Tfs*78) | Frameshift | Forkhead | De novo | Trio-exome | Pathogenic | Novel |
28 | 28 | 192 | c.755 G > A | p.(G252D) | Missense | Forkhead | De novo | NGS panel epilepsy | Likely pathogenic | Novel |
29 | 29 | 33 | c.921 C > G | p.(Y307*) | Nonsense | C-terminal | De novo | FOXG1 Sanger sequencing | Pathogenic | Novel |
25 | 25 | 89 | c.974dupT | p.(L325Ffs*130) | Frameshift | C-terminal | De novo | Exome | Pathogenic | Novel |
26 | 26 | 31 | c.1082dupG | p.(L362Pfs*93) | Frameshift | C-terminal | De novo | Trio-exome | Pathogenic | Novel |
27 | 27 | 204 | c.1141delG | p.(A381Pfs*4) | Frameshift | C-terminal | De novo | NGS panel epileptic encephalopathy | Pathogenic | Novel |